Opportunities to improve the electronic reporting system for adverse drug reactions in Mexico: A comparative evaluation with the United States of America and the European Union.
Miguel Á Cano-SandovalGabriela C López-ArmasYocanxóchitl Perfecto-AvalosAlan O Vázquez-AlvarezLorena Michele Brennan-BourdonPublished in: Pharmacoepidemiology and drug safety (2020)